Volker Knappertz
Director/Board Member presso Sutura Therapeutics Ltd.
Patrimonio netto: 276 803 $ in data 31/03/2024
Profilo
Volker Knappertz occupa la posizione di Chief Medical Officer per GW Pharmaceuticals Plc. Il Dr. Knappertz ha precedentemente occupato la posizione di vicepresidente dello sviluppo clinico presso Teva Pharmaceuticals Ltd. Il Dr. Knappertz ha ricevuto un dottorato dalla Universitt zu Kln.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 06/03/2024 | 55 250 ( 0.04% ) | 276 803 $ | 31/03/2024 |
Posizioni attive di Volker Knappertz
| Società | Posizione | Inizio |
|---|---|---|
Sutura Therapeutics Ltd.
 Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Director/Board Member | 01/09/2021 |
Precedenti posizioni note di Volker Knappertz
| Società | Posizione | Fine |
|---|---|---|
| GW PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Teva Pharmaceuticals Ltd.
 Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Corporate Officer/Principal | 01/05/2017 |
| AURINIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Volker Knappertz
| Universität zu Köln | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Teva Pharmaceuticals Ltd.
Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Health Technology |
Sutura Therapeutics Ltd.
Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Commercial Services |
- Borsa valori
- Insiders
- Volker Knappertz
